Seres Therapeutics (MCRB) Assets (2014 - 2026)
Seres Therapeutics (MCRB) reported Assets of $101.59 million for Q2 2026, down 29.4% from $143.8 million a year earlier and down 13.6% from the prior quarter.
Powered by 
Analysis
Seres Therapeutics (MCRB) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Seres Therapeutics posted Assets of $138.19 million, down 1.2% from FY2024.
- Assets has a five-year compound annual growth rate of -16.6% (FY2020 to FY2025).
- By year, Assets came in at $139.81 million in FY2024 (-61.0%), $358.6 million in FY2023 (+2.8%), $348.78 million in FY2022 (-1.7%) and $354.86 million in FY2021 (+3.5%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q2 2020.
- Year over year, Assets has now declined in each of the last nine quarters, with an average decline of 37.3% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q2 2023 (growth of 48.8%); the low point was Q4 2024 (a decline of 61.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $117.62 million (Q1 2026), $138.19 million (Q4 2025) and $143.47 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 613.62 Bn | 532.15 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 501.46 Bn | 474.57 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 366.84 Bn | 321.22 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 297.85 Bn | 261.84 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 261.66 Bn | 235.34 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 235.39 Bn | 190.79 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 169.57 Bn | 116.22 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Seres Therapeutics | 22.71 Mn | -116.12 Mn | - | 101.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 101.59 Mn |
| Mar 31, 2026 | 117.62 Mn |
| Dec 31, 2025 | 138.19 Mn |
| Sep 30, 2025 | 143.47 Mn |
| Jun 30, 2025 | 143.80 Mn |
| Mar 31, 2025 | 164.18 Mn |
| Dec 31, 2024 | 139.81 Mn |
| Sep 30, 2024 | 178.74 Mn |
| Jun 30, 2024 | 321.73 Mn |
| Mar 31, 2024 | 341.26 Mn |
| Dec 31, 2023 | 358.60 Mn |
| Sep 30, 2023 | 367.70 Mn |
| Jun 30, 2023 | 406.39 Mn |
| Mar 31, 2023 | 270.19 Mn |
| Dec 31, 2022 | 348.78 Mn |
| Sep 30, 2022 | 311.87 Mn |
| Jun 30, 2022 | 273.20 Mn |
| Mar 31, 2022 | 319.89 Mn |
| Dec 31, 2021 | 354.86 Mn |
| Sep 30, 2021 | 396.29 Mn |
API Access
Seres Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MCRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MCRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MCRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();